NASDAQ
217.61USD
-0.25 (-0.11%)
We have scored 8 news catalysts on iShares Biotechnology ETF (IBB) over the past 12 months. The biggest single-day move next to one of them came Mar 21, 2026, when IBB closed −1.7%: “DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing”. Coverage across the window leans mixed (average ticker sentiment +0.05). Most of the impact sits in sector healthcare and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
11.5B
P/E
—
EPS
—
Beta
0.70
52W range
154.62-222.29
Day range
216.19–222.29
Open
218.56
Prev close
217.86
Volume
3.5M
Avg volume
1.6M
Dividend
0.41
IPO
2001-02-12
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about iShares Biotechnology ETF — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for IBB: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
